**Meet the editor**

Dr Mohamed A. Abdelaal, MD, FRCPath, FRCPI, is a senior Consultant Hematologist at the Adult Hematology/ Adult BMT, Princess Noorah Oncology Center, King Abdulaziz Medical City, Jeddah, Saudi Arabia. He trained in hematology at the Hammersmith Hospital and the London Hospital in Whitechapel, UK, before he took up his current position in 1987. In addition, Dr Abdelaal

holds the position of Chairman of Pathology and Laboratory Medicine, and Head of King Abdullah International Medical Research Center. Dr Abdelaal holds several achievement awards and is very active on various fronts of teaching, academics, and research with over 90 publications, management, quality improvement and auditing. His areas of research interest are thromboembolism, leukemia and lymphoma.

Contents

**Preface VII** 

**Section 1 Some Aspects of Pathogenesis of Thrombosis 1** 

**and Venous Thromboembolism 17**  Nadja Plazar and Mihaela Jurdana

Chapter 2 **Hyperhomocysteinemia: Relation to Cardiovascular Disease** 

**Section 2 Venous Thromboembolism in Certain Groups of Patients 35** 

Pedro Pablo García Lázaro, Gladys Patricia Cannata Arriola, Gloria Soledad Cotrina Romero and Pedro Arauco Nava

Chapter 3 **Venous Thromboembolism in Neonates, Children and Patients with Chronic Renal Disease –** 

Chapter 4 **Venous Thromboembolism in Cancer Patients 73**  Galilah F. Zaher and Mohamed A. Abdelaal

Chapter 5 **Thrombosis Associated with Immunomodulatory Agents** 

Jose Ramon Gonzalez-Porras and María-Victoria Mateos

**a Preventable Patient Injury: Experience of the Danish Patient Insurance Association (1996 - 2010) 159**  Jens Krogh Christoffersen and Lars Dahlgaard Hove

Chapter 1 **Microparticles: Role in Haemostasis and Venous Thromboembolism 3**  Anoop K. Enjeti and Michael Seldon

**Special Considerations 37** 

**in Multiple Myeloma 115** 

Chapter 6 **Aetiology of Deep Venous Thrombosis - Implications for Prophylaxis 131**  Paul S. Agutter and P. Colm Malone

Chapter 7 **Venous Thromboembolism as** 

**Section 3 Emerging Issues in Thromboprophylaxis 129** 
